Edition:
United States

GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,582.00GBp
24 May 2019
Change (% chg)

10.40 (+0.66%)
Prev Close
1,571.60
Open
1,577.60
Day's High
1,586.80
Day's Low
1,570.60
Volume
5,536,709
Avg. Vol
7,308,432
52-wk High
1,648.80
52-wk Low
1,408.80

About

GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare... (more)

Overall

Beta: 1.21
Market Cap(Mil.): £75,181.28
Shares Outstanding(Mil.): 4,918.63
Dividend: 19.00
Yield (%): --

Financials

  GSK.L Industry Sector
P/E (TTM): 38.75 29.30 32.55
EPS (TTM): 0.39 -- --
ROI: 7.58 14.23 13.82
ROE: 278.84 15.46 15.25

UPDATE 1-GSK brings back bonuses for some sales reps

May 23 British drugmaker GlaxoSmithKline said on Thursday it will reintroduce incentive payments for sales representatives in some countries to retain talent after stopping them for years in the wake of scandals over illegal sales practices.

May 23 2019

GSK's shingles vaccine approved for use in China in adults aged 50 and above

GlaxoSmithKline Plc said on Thursday its shingles vaccine had been approved for use in China in adults aged 50 and above.

May 23 2019

UPDATE 1-GSK's shingles vaccine approved for use in China in adults aged 50 and above

May 23 GlaxoSmithKline Plc said on Thursday its shingles vaccine had been approved for use in China in adults aged 50 and above.

May 23 2019

GSK's shingles vaccine approved for use in China in adults aged 50 and above

May 23 GlaxoSmithKline Plc said file:///C:/Users/U6070662/AppData/Local/Fastwire/Download/-19962 2621/Press%20Release%20-%20GSK%20announces%20approval%20of%20Shi ngrix%20in%20China%20for%20prevention%20of%20shingles%20in%20adu lts%20aged%2050%20and%20over%2023052019.pdf on Thursday its shingles vaccine had been approved for use in China in adults aged 50 and above.

May 23 2019

GSK to change incentives for sales representatives

British drugmaker GlaxoSmithKline said on Thursday it will change incentives for sales representatives in some countries as it looks to retain talent.

May 23 2019

GSK to change incentives for sales representatives

May 23 British drugmaker GlaxoSmithKline said on Thursday it will change incentives for sales representatives in some countries as it looks to retain talent.

May 23 2019

GSK and Novartis liniment marketing misled Australian consumers: court

SYDNEY The Australian subsidiaries of British drugmaker GlaxoSmithKline and Swiss drugmaker Novartis misled customers and broke the law by promoting identical liniments as though they could treat specific ills, an Australian court found on Friday.

May 17 2019

GSK and Novartis liniment marketing misled Australian consumers -court

SYDNEY, May 17 The Australian subsidiaries of British drugmaker GlaxoSmithKline and Swiss drugmaker Novartis misled customers and broke the law by promoting identical liniments as though they could treat specific ills, an Australian court found on Friday.

May 17 2019

GSK-Pfizer deal gets approval from Australia's anti-trust watchdog

GlaxoSmithKline's deal to buy Pfizer's consumer healthcare business will not lesson competition in Australia, the country's anti-trust regulator said on Thursday as it approved the deal.

May 08 2019

UPDATE 1-GSK-Pfizer deal gets approval from Australia's anti-trust watchdog

May 9 GlaxoSmithKline's deal to buy Pfizer's consumer healthcare business will not lesson competition in Australia, the country's anti-trust regulator said on Thursday as it approved the deal.

May 08 2019

Earnings vs. Estimates